The Zyprexa Chronicles: Teen Bipolar Zyprexa Study Authors' Many Pharma Ties

As I noted earlier today, a new study of Zyprexa use in teens was just published. I've just reviewed the full paper and will have more thoughts in a bit. Until then, take a look at the disclosure statement for the study authors at the end of the paper:

"Drs. Tohen and Kryzhanovskaya are employees and shareholders with Eli Lilly. Dr. Carlson reports affiliations with Eli Lilly, Otsuka, Shire, Janssen, Bristol-Myers Squibb, Sanofi-Aventis, Cephalon, and NIMH. Dr. DelBello has served as a consultant and has received research support from Eli Lilly; she has received research support from and served as a consultant and speaker for AstraZeneca; she has served as a consultant for and received research support from Johnson and Johnson and Pfizer; she has served as a speaker for GlaxoSmithKline, and she has received research support from Shire. Dr. Wozniak has served as a consultant for Pfizer and Shire Pharmaceuticals; she has received research funding from Eli Lilly and NIMH; and she has served on the speaker's bureaus of Eli Lilly and Janssen; her spouse has served on the speaker's bureaus of Cephalon, Sanofi Aventis, Sepracor, GlaxoSmithKline, and Takeda; he has served on the advisory boards of Pfizer, GlaxoSmithKline, Sepracor, SchwarzPharma, Takeda, and Boehringer-Ingelheim; and he has received research support from Pfizer, GlaxoSmithKline, UCB Pharma, Boehringer-Ingelheim, and Schwarz-Pharma. Dr. Kowatch has received research support from Bristol-Myers Squibb, Stanley Research Foundation, NIMH, and NICHD; he has served as a consultant/advisory board member for Creative Educational Concepts, Child and Adolescent Bipolar Foundation, and Abbott; he has served as Editor of Current Psychiatry; and he has served on the speaker's bureaus of AstraZeneca and Abbott. Dr. Wagner has received research support from NIMH; and she has served as a consultant and advisory board member for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Janssen, Novartis, Otsuka, Pfizer, Sanofi Aventis, and Solvay. Dr. Findling has received research support, acted as a consultant, and/or served on a speaker’s bureau for Abbott, AstraZeneca, Bristol-Myers Squibb, Celltech Medeva, Cypress Biosciences, Forest, GlaxoSmithKline, Johnson and Johnson, Eli Lilly, New River, Novartis, Otsuka, Pfizer, Sanofi-Aventis, Sepracore, Shire, Solvay, Supernus Pharmaceuticals, and Wyeth. Drs. Lin, RobertsonPlouch, and Xu are employed by Eli Lilly. Dr. Dittmann is an employee and shareholder with Eli Lilly. Dr. Biederman has received research support from and has served as a speaker or advisory board member for Shire, Eli Lilly, Pfizer, McNeil Abbott, Bristol-Myers Squibb, New River Pharmaceuticals, Cephalon, Janssen, Novartis, UCB Pharma, AstraZeneca, Forest Laboratories, GlaxoSmithKline, and Neurosearch; he has also received research support from the Stanley Medical Institute, Lilly Foundation, Prechter Foundation, NIMH, NICHD, and NIDA. Sponsored by Eli Lilly and Company."

Fascinating, eh? Why isn't the study author simply listed as Eli Lilly?